Insider · CIK 0001872210
Neil Bhowmick
Files at KAPA (Kairos Pharma, LTD.). First filing -, latest -.
Neil Bhowmick files SEC Form 4 as officer at KAPA (Kairos Pharma, LTD.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Neil Bhowmick has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | KAPA Kairos Pharma, LTD. | AGrant or award COMMON STOCK | +171,756 | $0.00 | $0 | 1,311,739 | Dec 30, 2025 |
| Jan 1, 2025 | KAPA Kairos Pharma, LTD. | AGrant or award COMMON STOCK | +14,000 | $0.00 | $0 | 1,139,983 | Apr 7, 2025 |
Questions about Neil Bhowmick
Answered from the filings on this page, as of the latest one.
Is Neil Bhowmick buying or selling?
Neil Bhowmick has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Neil Bhowmick's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neil Bhowmick has 0.
Where does Neil Bhowmick file Form 4?
Neil Bhowmick has filed Form 4 at KAPA (Kairos Pharma, LTD.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.